PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+27%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$577M
AUM Growth
+$577M
(+25%)
Cap. Flow
+$87.3M
Cap. Flow
% of AUM
15.13%
Top 10 Holdings %
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13
Top Buys
| 1 |
Cencora
COR
|
$16.6M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$15.9M |
| 3 |
Becton Dickinson
BDX
|
$11.6M |
| 4 |
Danaher
DHR
|
$10.9M |
| 5 |
Insulet
PODD
|
$8.45M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.5M |
| 2 |
Elevance Health
ELV
|
$9.95M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.72M |
| 4 |
Eli Lilly
LLY
|
$9.5M |
| 5 |
IQVIA
IQV
|
$9.08M |
Sector Composition
| 1 | Healthcare | 98.94% |
| 2 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Natera
NTRA
$23B
| $3.65M | 0.63% |
75,039
-50,004
| -40% | -$2.43M |
|
52
Evolent Health
EVH
$1.11B
| $3.62M | 0.63% |
119,492
-67,431
| -36% | -$2.04M |
|
53
Edgewise Therapeutics
EWTX
$1.54B
| $3.52M | 0.61% |
454,247
+391,964
| +629% | +$3.04M |
|
|
AKYA
54
DELISTED
Akoya BioSciences
AKYA
| $3.48M | 0.6% |
471,000
+269,615
| +134% | +$1.99M |
|
|
SAGE
55
DELISTED
Sage Therapeutics
SAGE
| $3.29M | 0.57% |
70,033
+44,712
| +177% | +$2.1M |
|
56
KORU Medical Systems
KRMD
$187M
| $3.1M | 0.54% |
899,063
+47,688
| +6% | +$165K |
|
57
Lexicon Pharmaceuticals
LXRX
$392M
| $3.05M | 0.53% |
1,330,616
+655,288
| +97% | +$1.5M |
|
58
IDEAYA Biosciences
IDYA
$2.26B
| $2.99M | 0.52% |
+127,339
| New | +$2.99M |
|
59
Esperion Therapeutics
ESPR
$490M
| $2.96M | 0.51% |
2,132,309
+253,452
| +13% | +$352K |
|
|
SWAV
60
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.88M | 0.5% |
10,076
-36,779
| -78% | -$10.5M |
|
61
NewAmsterdam Pharma
NAMS
$2.8B
| $2.84M | 0.49% |
239,051
+124,051
| +108% | +$1.47M |
|
62
Black Diamond Therapeutics
BDTX
$164M
| $2.53M | 0.44% |
+500,000
| New | +$2.53M |
|
|
LBPH
63
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.51M | 0.43% |
+341,587
| New | +$2.51M |
|
|
CDMO
64
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.49M | 0.43% |
177,900
-276,052
| -61% | -$3.86M |
|
65
Arvinas
ARVN
$580M
| $2.48M | 0.43% |
+100,000
| New | +$2.48M |
|
66
Lyra Therapeutics
LYRA
$11.8M
| $2.47M | 0.43% |
+600,000
| New | +$2.47M |
|
67
Arcus Biosciences
RCUS
$1.24B
| $2.44M | 0.42% |
120,049
+17,062
| +17% | +$347K |
|
68
Acadia Pharmaceuticals
ACAD
$4.34B
| $2.4M | 0.42% |
+100,000
| New | +$2.4M |
|
69
Axogen
AXGN
$718M
| $2.38M | 0.41% |
260,858
+37,075
| +17% | +$338K |
|
70
Travere Therapeutics
TVTX
$1.75B
| $2.25M | 0.39% |
146,323
+4,436
| +3% | +$68.1K |
|
71
Disc Medicine
IRON
$2.14B
| $2.22M | 0.38% |
+50,000
| New | +$2.22M |
|
72
Liquidia Corp
LQDA
$2.52B
| $2.21M | 0.38% |
281,134
-45,831
| -14% | -$360K |
|
73
Cogent Biosciences
COGT
$1.83B
| $2.2M | 0.38% |
185,782
+3,886
| +2% | +$46K |
|
74
CVRx
CVRX
$204M
| $2.17M | 0.38% |
+140,763
| New | +$2.17M |
|
75
Castle Biosciences
CSTL
$673M
| $2.03M | 0.35% |
+148,002
| New | +$2.03M |
|